| Literature DB >> 31891097 |
Jeenat Aslam1, Irfan Hussain Lone1, Nagi R E Radwan1, Mohd Faizan Siddiqui2, Shazia Parveen1, Rua B Alnoman1, Ruby Aslam3.
Abstract
Binding effect and interaction of N,N'-dialkyl cystine based gemini surfactant (GS); 2(C12Cys) with human serum albumin (HSA) were systematically investigated by the techniques such as surface tension measurement, UV-visible spectroscopy, fluorescence spectroscopy, circular dichroism (CD) spectroscopy, and molecular docking studies. The surface tension measurement exhibited that HSA shifted the critical micelle concentration of the 2(C12Cys) GS to the higher side that confirms the complex formation among 2(C12Cys) GS and HSA which was also verified by UV-visible, fluorescence, and CD spectroscopy. Increase in the concentration of 2(C12Cys) GS increases the absorption of the HSA protein but has a reverse effect on the fluorescence intensity. The analysis of UV-visible study with the help of a static quenching method showed that the value acquired for the bimolecular quenching constant (k q) quenches the intrinsic fluorescence of the HSA protein. Synchronous fluorescence spectrometry declared that the induced-binding conformational changes in HSA and CD results explained the variations in the secondary arrangement of the protein in presence of 2(C12Cys) GS. The present study revealed that the interaction between 2(C12Cys) GS and HSA is important for the preparation and properties of medicines. Molecular docking study provides insight into the specific binding site of 2(C12Cys) GS into the sites of HSA.Entities:
Year: 2019 PMID: 31891097 PMCID: PMC6933778 DOI: 10.1021/acsomega.9b03315
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Surface tension profile of 2(C12Cys) GS in the absence and presence of 4 μM HSA in buffer solution (pH 7.4).
Surface Properties (cmc, ∏cmc, Γmax, Amin, ΔGm°, and ΔGads°) for 2 (C12Cys) GS in the Absence and Presence of 4 μM HSA (Aqueous Solution, pH 7.4) at 25 °C
| sample | cmc (mM) | γcmc (mN/m−1) | ∏cmc (mN/m−1) | Γmax (107 × mol/m−2) | Δ | Δ | |
|---|---|---|---|---|---|---|---|
| 2(C12Cys) | 0.0011 | 35.14 | 35.86 | 18.01 | 92.18 | –27.28 | –29.27 |
| 2(C12Cys) + HSA | 0.00087 | 41.08 | 29.92 | 20.26 | 81.93 | –27.87 | –29.35 |
Figure 2Fluorescence quenching results of the HSA/2(C12Cys) GS system: (a) quenching profiles with varying concentrations of the surfactant, (b) Stern–Volmer plot, and (c) modified Stern–Volmer plot.
Stern–Volmer Quenching Constant (KSV), Bimolecular Quenching Constant (kq), Binding Constant (Ka), and Binding Sites (n) for the Binding of 2(C12Cys) GS with HSA in Buffer Solution (pH 7.4) at 25 °C
| sample | Δ | |||||
|---|---|---|---|---|---|---|
| 2(C12Cys) + HSA | 4.41 | 4.41 | 0.989 | 3.11 | 1.19 | –25.63 |
Figure 3Synchronous spectra of HSA in the presence of varying concentrations of 2(C12Cys) GS at 298 K (a) Δλ = 15 nm (represents contributions due to tyrosine), and (b) Δλ = 60 nm (represents contributions due to tryptophan).
Figure 4UV–vis absorption spectra of HSA (4 μM) in the absence and presence of various concentrations of 2(C12Cys) GS.
Figure 5Far UV-CD spectra of HSA (4 μM) in the absence and presence of various concentrations of 2(C12Cys) GS.
Figure 6(a) binding sites of HSA, (b) docked pose of the compound into the binding sites of HSA, (compound is shown in colored spheres), (c) zoomed-in view showing the interactions of the compound with the residues of HSA (compound is shown in spheres).